Cantor Fitzgerald Downgrades NVIDIA (NVDA) to Hold; More Cautious Going Forward
Tweet
Share
E-mailGet Alerts NVDA Hot Sheet
Price: $225.16 -0.06%
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald downgraded NVIDIA (NASDAQ: NVDA) from Buy to Hold with a price target of $13.50 (from $20.00).
Analyst, Dale R. Pfau, said, "We remind investors that approximately 80% of Nvidia revenues are tied to sectors of the PC and computer ecosystem. While Nvidia continues to do well in these segments, we expect little to no growth over the next several years...The remaining 20% of revenues (Consumer Products) are coming primarily from sales of GPUs (Tegra and others) into the non-Apple tablet market and to a lesser extent into the handset market. In our opinion, Nvidia's success in the tablet market is already reflected in the share price."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $13.73 yesterday.
Analyst, Dale R. Pfau, said, "We remind investors that approximately 80% of Nvidia revenues are tied to sectors of the PC and computer ecosystem. While Nvidia continues to do well in these segments, we expect little to no growth over the next several years...The remaining 20% of revenues (Consumer Products) are coming primarily from sales of GPUs (Tegra and others) into the non-Apple tablet market and to a lesser extent into the handset market. In our opinion, Nvidia's success in the tablet market is already reflected in the share price."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $13.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
- Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
